UT-PROTEGRITY
18.11.2021 15:02:07 CET | Business Wire | Press release
Protegrity , a global leader in data security, today announced the availability of the Protegrity Data Protection Platform and Cloud Protect for Snowflake in the Microsoft Azure Marketplace, an online store providing applications and services for use on Microsoft Azure. Protegrity customers can now take advantage of the scalability, high availability, and security of Azure, with streamlined deployment and management.
Additionally, Protegrity has achieved Microsoft’s stringent Co-Sell Ready designation, unlocking the development of joint solutions, sales, and support through the Microsoft One Commercial Partner Program. Protegrity has also joined the Microsoft FastTrack certification program.
“Due to heightened sensitivity over data and privacy, many organizations have been slower to adopt cloud solutions,” said Jay Chitnis, vice president, global alliances and partners at Protegrity. “However, we’re now seeing a tipping point with businesses. Many of them want to make the most of the cloud to support AI and machine learning initiatives, so they can gain valuable insights from data, but they also recognize they have to safeguard the privacy of their customers, partners, and employees. That’s why it’s critical for organizations to secure data in any form and wherever it is—in the cloud or on premises—so it can be accessed across the enterprise by front-line employees, analytics teams, and anyone who needs data intelligence to make business decisions. Our collaboration with Microsoft ensures our mutual customers’ data is not at risk as it moves to the cloud, allowing organizations to accelerate cloud adoption.”
Jake Zborowski, general manager, Microsoft Azure Platform at Microsoft Corp., said, “We’re pleased to welcome Protegrity's solutions to the Microsoft Azure Marketplace, which gives our partners great exposure to cloud customers around the globe. Azure Marketplace offers world-class quality experiences from global trusted partners with solutions tested to work seamlessly with Azure.”
The Azure Marketplace is an online market for buying and selling cloud solutions certified to run on Azure. The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.
Seamless Data Protection to Support Advanced Analytics, AI, and Machine Learning on Microsoft Azure
As part of the Co-Sell Ready achievement, Protegrity met Microsoft’s strict architecture and security requirements. Protegrity will also continue to work with Microsoft account teams and partners to seamlessly deliver modern data protection and data privacy solutions to joint customers while supporting advanced analytics, AI, and machine learning, and Microsoft Azure cloud initiatives. Additionally, as part of the FastTrack program, Protegrity’s commitment to Microsoft Azure-based solutions will provide native security and performance for mutual customers.
Protegrity’s enterprise-class Data Protection Platform integration with Microsoft Azure enables customers to apply data-protection policies across different environments, entities, and jurisdictions. Additionally, customers are able to:
- Secure data moving to the cloud to reduce operational risk;
- Govern data in the cloud leveraging enterprise-wide information security policies; and
- Unlock and secure data analytics capabilities in the cloud.
Built for hybrid-cloud and multi-cloud, the Protegrity Data Protection Platform allows companies to seamlessly deploy and update data security policies across geographies, departments, and digital transformation programs. Businesses can quickly and safely turn sensitive data into intelligence-driven insights to deliver better customer experiences, monetize data responsibly, and support AI and machine learning initiatives.
Protegrity Data Protection Platform and Cloud Protect for Snowflake on Microsoft Azure Safeguard Sensitive Data for Privacy Compliance
Now available on the Microsoft Azure Marketplace, the Protegrity Data Protection Platform provides customers with fine-grained data protection capabilities for sensitive data and compliance. Protegrity accelerates analytics; minimizes risk in enterprise cloud adoption and migration; and meets storage, big data, and workload requirements. With its format-preserving vaultless tokenization capabilities and other forms of encryption, Protegrity safeguards data throughout every step of the data lifecycle.
Protegrity also announced the availability of Cloud Protect for Snowflake , which bundles two serverless components, the Snowflake Protector and Cloud API, to protect customers’ data and accelerate cloud migration and adoption of Snowflake.
- Snowflake Protector: The Snowflake Protector is a purpose-built protector that integrates seamlessly with Snowflake SQL to easily protect and unprotect sensitive data. Elastically scalable and benchmarked for high performance, the Protegrity Snowflake Protector enables organizations to support even the largest workloads.
- Cloud API: The Cloud API provides a general tokenization REST endpoint for use within ETL workflows. It can be used to protect data prior to ingestion into Snowflake, ensuring that data is always protected at rest.
With its support for Microsoft Azure, Protegrity continues to deliver on its commitment to expand cloud-inclusivity, enabling customers to maintain enterprise-wide data protection wherever sensitive data resides. Support for Microsoft points to one of many integrations Protegrity has with cloud providers as part of the new Protegrity Partner Network —a collaboration with leading technology companies that enables organizations to protect data in the cloud, regardless of vendor. With the freedom to safeguard data in any cloud system or application, organizations can unlock the potential of secure data no matter where it is and create more opportunities for innovation and digital transformation and improve customer experiences.
Learn more
Website: protegrity.com
Twitter: @Protegrity
LinkedIn: linkedin.com/company/protegrity
About Protegrity
Protegrity, a global leader in data security, protects sensitive data everywhere and future-proofs businesses as data-privacy regulations evolve. Maintaining privacy today across distributed data has become impossibly complicated. With Protegrity, enterprises can secure data wherever it resides, control how it’s protected, and have confidence that data is safe, even if a breach occurs. The Protegrity Data Protection Platform is a modern alternative to traditionally complex data-protection methods that leave gaps in security. Whether encrypting, tokenizing, or applying privacy models, Protegrity protects data at the speed of business. Deep integrations with Snowflake, Amazon Redshift, Teradata, Oracle, Microsoft SQL Server, Cloudera, Databricks, and many other enterprise applications ensure that data remains fully protected in hybrid-cloud, multi-cloud, and on-premises environments. The platform’s fine-grained data protection anonymizes personally identifiable information (PII) that’s used in AI and machine learning models, providing faster access to critical analytics data and dramatically shortening the time to business insights. Protegrity protects the sensitive data of more than two billion individuals across global enterprises, including four of the world’s 15 largest banks, four out of 10 of the top health insurance providers, and three of the world’s leading multinational companies. With more than two decades of industry-leading innovation, Protegrity allows businesses to finally tap into the value of their data and accelerate digital transformation timelines – without jeopardizing individuals’ fundamental right to privacy.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211118005259/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release
Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release
The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release
Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
